摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

diethyl (4-hydroxy-3,5-dimethylphenylsulfanylmethyl)phosphonate | 1085957-26-1

中文名称
——
中文别名
——
英文名称
diethyl (4-hydroxy-3,5-dimethylphenylsulfanylmethyl)phosphonate
英文别名
4-(Diethoxyphosphorylmethylsulfanyl)-2,6-dimethylphenol
diethyl (4-hydroxy-3,5-dimethylphenylsulfanylmethyl)phosphonate化学式
CAS
1085957-26-1
化学式
C13H21O4PS
mdl
——
分子量
304.347
InChiKey
URIIZRAIQFLJIE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    19
  • 可旋转键数:
    7
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.54
  • 拓扑面积:
    81.1
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    diethyl (4-hydroxy-3,5-dimethylphenylsulfanylmethyl)phosphonate 、 bis(3-isopropyl-4-methoxyphenyl)iodonium tetrafluoroborate 在 三乙胺 作用下, 以 二氯甲烷 为溶剂, 以60%的产率得到diethyl [4-(4'-methoxy-3'-isopropylphenoxy)-3,5-dimethyl-phenylsulfanylmethyl]phosphonate
    参考文献:
    名称:
    Synthesis and Biological Evaluation of a Series of Liver-Selective Phosphonic Acid Thyroid Hormone Receptor Agonists and Their Prodrugs
    摘要:
    Phosphonic acid (PA) thyroid hormone receptor (TR) agonists were synthesized to exploit the poor distribution of PA-based drugs to extrahepatic tissues and thereby to improve the therapeutic index. Nine PAs showed excellent TR binding affinities (TR beta(1), K-i < 10 nM), and most of them demonstrated significant cholesterol lowering effects in a cholesterol-fed rat (CFR) model. Unlike the corresponding carboxylic acid analogue and T-3, PA 22c demonstrated liver-selective effects by inducing maximal mitochondrial glycerol-3-phosphate dehydrogenase activity in rat liver while having no effect in the heart. Because of the low oral bioavailability of PA 22c, a series of prodrugs was synthesized and screened for oral efficacy in the CFR assay. The liver-activated cyclic 1-(3-chlorophenyl)-1,3-propanyl prodrug (MB07811) showed potent lipid lowering activity in the CFR (ED50 0.4 mg/kg, po) and good oral bioavailability (40%, rat) and was selected for development for the treatment of hypercholesterolemia.
    DOI:
    10.1021/jm800824d
  • 作为产物:
    描述:
    diethyl (3,5-dimethyl-4-triisopropylsilanyloxyphenylsulfanyl)methylphosphonate四丁基氟化铵 作用下, 以 四氢呋喃 为溶剂, 反应 2.0h, 以85%的产率得到diethyl (4-hydroxy-3,5-dimethylphenylsulfanylmethyl)phosphonate
    参考文献:
    名称:
    Synthesis and Biological Evaluation of a Series of Liver-Selective Phosphonic Acid Thyroid Hormone Receptor Agonists and Their Prodrugs
    摘要:
    Phosphonic acid (PA) thyroid hormone receptor (TR) agonists were synthesized to exploit the poor distribution of PA-based drugs to extrahepatic tissues and thereby to improve the therapeutic index. Nine PAs showed excellent TR binding affinities (TR beta(1), K-i < 10 nM), and most of them demonstrated significant cholesterol lowering effects in a cholesterol-fed rat (CFR) model. Unlike the corresponding carboxylic acid analogue and T-3, PA 22c demonstrated liver-selective effects by inducing maximal mitochondrial glycerol-3-phosphate dehydrogenase activity in rat liver while having no effect in the heart. Because of the low oral bioavailability of PA 22c, a series of prodrugs was synthesized and screened for oral efficacy in the CFR assay. The liver-activated cyclic 1-(3-chlorophenyl)-1,3-propanyl prodrug (MB07811) showed potent lipid lowering activity in the CFR (ED50 0.4 mg/kg, po) and good oral bioavailability (40%, rat) and was selected for development for the treatment of hypercholesterolemia.
    DOI:
    10.1021/jm800824d
点击查看最新优质反应信息